期刊文献+

固本益肠片联合美沙拉嗪片治疗中重度溃疡性结肠炎19例 被引量:11

Clinical Observation on GuBen YiChang Tablets and Mesalazine Tablets in Treating Moderate and Severe Ulcerative Colitis:A Report of 19 Cases
暂未订购
导出
摘要 目的:观察固本益肠片联合美沙拉嗪片治疗中重度溃疡性结肠炎的疗效。方法:将符合纳入标准的40例患者随机分为治疗组和对照组,对照组采用美沙拉嗪片1.0g,3次/d,口服;甲基强的松龙60~80 mg,1次/d静脉滴注,另据病情选择抗生素治疗。治疗组在此基础上加服固本益肠片,4片/次,3次/d,口服;治疗1个月后,观察2组疗效并测定治疗前后患者C反应蛋白(CRP)、IL-10水平。结果:固本益肠片联合美沙拉嗪片治疗中重度溃疡性结肠炎疗效显著,治疗组总有效率95.24%,对照组总有效率68.24%,2组差异有统计学意义(P<0.05)。结论:联合应用固本益肠片能提高中重度溃疡性结肠炎的临床疗效,并能减少结肠炎性反应水平。 Objective:To observe clinical effects of GuBen YiChang tablets and mesalazine tablets to moderate and severe ulcerative colitis.Method:Forty patients were randomized into the treatment group and the control group.The control group took mesalazine tablets 1.0 g,three times each day;intravenous dripping of methylprednisolone,60 to 80 mg,once each day,choosing antibiotics according to the disease condition.On the basis,the treatment group received GuBen YiChang tablets orally,four pills once,three times each day;after treating for one month,clinical effects of both groups were observed and the contents of CRP and IL-10 were detected before and after treating.Result:GuBen YiChang tablets and mesalazine tablets were effective in treating moderate and severe ulcerative colitis,total effective rate of the treatment group was 95.24%,higher than 68.24% of the control group with statistical meaning(P0.05).Conclusion:GuBen YiChang tablets combined with mesalazine tablets can improve therapeutic effects in treating moderate and severe ulcerative colitis and alleviate inflammatory reaction of colon.
机构地区 唐山市人民医院
出处 《西部中医药》 2013年第1期79-80,共2页 Western Journal of Traditional Chinese Medicine
基金 唐山市科学技术研究与发展指导计划项目(编号111302100b)
关键词 结肠炎 溃疡性 美沙拉嗪片 固本益肠片 C反应蛋白 IL-10 colitis ulcerative mesalazine tablets GuBen YiChangtablets Creactiveprotein(CRP) IL-10
  • 相关文献

参考文献8

二级参考文献30

  • 1欧阳钦,王一平.纤维结肠镜对溃疡性结肠炎诊断的作用和限度:(附116例分析)[J].内镜,1993,10(1):6-9. 被引量:35
  • 2项平,徐富星,欧平安.溃疡性结肠炎486例结肠镜检查的评价和分析[J].中华消化杂志,1996,16(3):136-138. 被引量:89
  • 3Thompson NP, Wakefidd AJ, Pounder RE. Inherited diseases of coagulation appear to protect against inflammatory bowel disease.Gastroenterology, 1995, 108(4) : 1011 -- 1015.
  • 4Dhillon AP,Anthongy A, Sim R, et al. Mucosal capillary thrombi in rectal biopsies. Histopatbology, 1992;21 (2) :127~133.
  • 5Gaffney PR, Doyle CT, Gaffney A, et al. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol,1995;90 (2): 220~223.
  • 6Folwaczny C, Wiehecke B, Loeschke K. Unfractioned heparin in the therapy of patlents with highly active inflammatory bowel disease .Am J Gastroenterol, 1999;94(6): 1551--1555.
  • 7Ang YS, Mahrnud N, White B ,et al. Randomizexl comparison of unfractioned heparinwith ccorficosteroids in seveze active inflammatory bowel disease. Aliment Pharmacol Ther,2000;14(8) : 1015--1022.
  • 8潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 9潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 10樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.

共引文献785

同被引文献204

引证文献11

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部